TRPV1 and carpal tunnel syndrome: The specific mechanism of D5W in the treatment of CTS has not been clarified, which may be related to its repression of transient receptor potential vanilloid receptor-1 (TRPV1) and the reduction of pain factors secreted by swollen nerves (35).